Arenicin-1 vs Epoetin Alfa
Head-to-head comparison of Arenicin-1 (Arenicin-1) and Epoetin Alfa (Recombinant human erythropoietin alfa) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | Epoetin Alfa |
|---|---|---|
| Category | Marine-Derived | Muscle & Performance |
| Full Name | Arenicin-1 | Recombinant human erythropoietin alfa |
| Molecular Weight | 2079 Da | ≈30,400 Da |
| Half-Life | n/a | ~4-13 h IV; ~20-30 h SC |
| Amino Acids | 21 | 165 |
| Typical Dose | n/a | 50-100 IU/kg SC 3x weekly or 40,000 IU SC weekly |
| Route | preclinical | Subcutaneous/IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 320 |
| Research Status | Pre-clinical | Clinical |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
Epoetin Alfa Benefits
- ✓raises hemoglobin
- ✓increases oxygen-carrying capacity
- ✓may increase VO2 max
- ✓improves time-to-exhaustion
Arenicin-1 Dosing
bacterial infection|biofilm disruption
Epoetin Alfa Dosing
50-100 IU/kg subcutaneous 3x weekly|40,000 IU subcutaneous weekly|Titrate to hemoglobin target under medical supervision
Arenicin-1 Side Effects
- ⚠Arenicola marina
Epoetin Alfa Side Effects
- ⚠hypertension
- ⚠thrombosis
- ⚠polycythemia
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
Epoetin Alfa
Human studies in anemia and performance-related settings show that increasing red-cell mass can improve aerobic capacity and endurance. It remains heavily regulated because excessive erythropoiesis raises thrombotic and cardiovascular risk.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.